{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:32:38Z","timestamp":1793172758409,"version":"4.5.0"},"reference-count":30,"publisher":"American Society of Consultant Pharmacists","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Consultant Pharmacist"],"published-print":{"date-parts":[[2013,3,1]]},"DOI":"10.4140\/tcp.n.2013.184","type":"journal-article","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T03:03:30Z","timestamp":1362539010000},"page":"184-188","source":"Crossref","is-referenced-by-count":9,"title":["Charles Bonnet Syndrome: Treating Nonpsychiatric Hallucinations"],"prefix":"10.4140","volume":"28","author":[{"given":"Ngoc-Diem","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Osterweil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2625","published-online":{"date-parts":[[2013,3,5]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/01.pra.0000396067.87343.fb","article-title":"Charles Bonnet syndrome: are medications necessary?","volume":"17","author":"KE Hartney","year":"2011","journal-title":"J Psychiatr Pract"},{"key":"2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1444-0938.2004.tb03167.x","article-title":"Rehabilitation in Charles Bonnet syndrome: a review of treatment options","volume":"87","author":"F Eperjesi","year":"2004","journal-title":"Clin Exp Optom"},{"key":"3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0039-6257(02)00414-9","article-title":"Complex visual hallucinations in the visually impaired: the Charles Bonnet syndrome","volume":"48","author":"GJ Menon","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"4","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1136\/bmj.328.7455.1552","article-title":"Charles Bonnet syndrome\u2014elderly people and visual hallucinations","volume":"328","author":"A Jacob","year":"2004","journal-title":"BMJ"},{"key":"5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.optm.2008.10.017","article-title":"Charles Bonnet syndrome: case presentation and literature review","volume":"80","author":"EM Kester","year":"2009","journal-title":"Optometry"},{"key":"6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1503\/cmaj.090049","article-title":"Charles Bonnet syndrome: visual loss and hallucinations","volume":"181","author":"ML Jackson","year":"2009","journal-title":"Can Med Assoc J"},{"key":"7","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0140-6736(96)90869-7","article-title":"Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome","volume":"347","author":"RJ Teunisse","year":"1996","journal-title":"Lancet"},{"key":"8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.optm.2010.11.014","article-title":"Charles Bonnet syndrome","volume":"82","author":"R Yacoub","year":"2011","journal-title":"Optometry"},{"key":"9","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1068\/p200809","article-title":"The Charles Bonnet syndrome: \u201cPhantom visual images\u201d","volume":"20","author":"G Schultz","year":"1991","journal-title":"Perception"},{"key":"10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00005053-199703000-00009","article-title":"The Charles Bonnet syndrome: a review","volume":"185","author":"A Fernadez","year":"1997","journal-title":"J Nerv Ment Dis"},{"key":"11","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4088\/JCP.v64n0921b","article-title":"Charles Bonnet syndrome with visual hallucinations of childhood experience: successful treatment of one patient with risperidone","volume":"64","author":"K Maeda","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"12","first-page":"787","article-title":"Mirtazapine for Charles Bonnet syndrome","volume":"49","author":"Z Siddiqui","year":"2004","journal-title":"Can J Psychiat"},{"key":"13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s10072-005-0455-0","article-title":"Olanzapine therapy in hallucinatory visions related to Bonnet syndrome","author":"M Colletti Moja","year":"2005","journal-title":"Neurol Sci"},{"key":"14","unstructured":"Pelak VS. Visual release hallucinations (Charles Bonnet syndrome). Uptodate August 2011. Retrieved from http:\/\/www.uptodate.com. <a target=\"_blank\" href='http:\/\/www.uptodate.com'>http:\/\/www.uptodate.com<\/a>"},{"key":"15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/0269881106075275","article-title":"Charles Bonnet syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors","volume":"21","author":"UE Lang","year":"2007","journal-title":"J Psychopharmacol"},{"key":"16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00004850-200411000-00008","article-title":"Treatment of typical Charles Bonnet syndrome with donepezil","volume":"19","author":"S Ukai","year":"2004","journal-title":"Int Clin Psychopharm"},{"key":"17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00019442-199911001-00159","article-title":"Cisapride in the treatment of visual hallucinations due to visual loss (the Charles Bonnet syndrome)","volume":"7","author":"N Ranen","year":"1999","journal-title":"Am J Geriatr Psychiatry"},{"key":"18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00004850-200015020-00009","article-title":"Treatment of Charles Bonnet syndrome with valproate","volume":"15","author":"H Hori","year":"2000","journal-title":"Int Clin Psychopharm"},{"key":"19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1192\/bjp.161.3.409","article-title":"Charles Bonnet syndrome","volume":"161","author":"MS Bhatia","year":"1992","journal-title":"Brit J Psychiatry"},{"key":"20","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/jnnp.70.6.813","article-title":"Charles Bonnet's syndrome; complete remission of complex visual hallucinations treated by gabapentin","volume":"70","author":"M Paulig","year":"2001","journal-title":"J Neurol Neurosur Psychiatry"},{"key":"21","unstructured":"Bundle K, Bodani M, Landham L. Pregabalin in the treatment of visual hallucinations in Charles Bonnet syndrome. Adv Clin Neurosci Rehabil June 2007. Available at www.acnr.co.uk\/pdfs\/Case20reports\/pregabalin_case_report.pdf, accessed October 4, 2011. <a target=\"_blank\" href='http:\/\/www.acnr.co.uk\/pdfs\/Case20reports\/pregabalin_case_report.pdf'>www.acnr.co.uk\/pdfs\/Case20reports\/pregabalin_case_report.pdf<\/a>"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Birks JS, Harvey R. Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst Rev 2003:CD001190.","DOI":"10.1002\/14651858.CD001190"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev 2006;1:CD005593.","DOI":"10.1002\/14651858.CD005593"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Birks J, Flicker L. Donepezil for mild cognitive impairment. Cochrane Database Syst Rev 2006;3:CD006104.","DOI":"10.1002\/14651858.CD006104"},{"key":"25","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00005053-199603000-00008","article-title":"A three-year follow-up study of visual hallucinations in patients with macular degeneration","volume":"184","author":"S Holroyd","year":"1996","journal-title":"J Nerv Ment Dis"},{"key":"26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/0145482X9208600605","article-title":"Benign visual hallucinations, or \u201cphantom vision\u201d in visually impaired and blind persons","volume":"86","author":"WW Needham","year":"1992","journal-title":"J Visual Impair Blind"},{"key":"27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/070674379203700411","article-title":"Charles Bonnet hallucinations: a case series","volume":"37","author":"MG Cole","year":"1992","journal-title":"Can J Psychiatry"},{"key":"28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0010-440X(89)90122-3","article-title":"Isolated visual hallucinations and the Charles Bonnet syndrome: a review of the literature and presentation of six cases","volume":"30","author":"K Gold","year":"1989","journal-title":"Compr Psychiatry"},{"key":"29","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1532-5415.1996.tb02937.x","article-title":"Charles Bonnet syndrome: an early marker for dementia?","volume":"44","author":"NH Pliskin","year":"1996","journal-title":"J Am Geriatr Soc"},{"key":"30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4088\/PCC.08r00673","article-title":"Visual hallucinations: differential diagnosis and treatment","volume":"11","author":"RC Teeple","year":"2009","journal-title":"Prim Care Companion J Clin Psychiatry"}],"container-title":["The Consultant Pharmacist"],"original-title":[],"deposited":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T07:44:51Z","timestamp":1595490291000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ingentaconnect.com\/content\/ascp\/tcp\/2013\/00000028\/00000003\/art00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,1]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3,1]]}},"alternative-id":["6G03245420236818"],"URL":"https:\/\/doi.org\/10.4140\/tcp.n.2013.184","relation":{},"ISSN":["0888-5109"],"issn-type":[{"value":"0888-5109","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3,1]]}}}